Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shortened Infusion Time of IV Ibuprofen for Fever or Pain
NCT01334944Phase 4Completed
- Sponsor
- Cumberland Pharmaceuticals
- Start
- Jun 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ibuprofen in fever and pain, sponsored by Cumberland Pharmaceuticals. Primary endpoint: Safety of a Single Dose of Intravenous Ibuprofen at 6 hours. Started Jun 2011; status: completed.
02
Drugs
ibuprofen
03
Conditions
feverpain
Beyond the preview
Go deeper on NCT01334944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01334944.